LMC Healthcare & LMC Manna Research will be in attendance at the 2018 American Diabetes Association’s 78th Scientific Sessions, June 22-26, at the Orange County Convention Center in Orlando, Florida! Come visit us at booth #1266!

Along with our attendance and numerous abstracts at ADA this year, Chief Medical Officer Dr. Ronnie Aronson has been selected to highlight the study  “First Assessment of the Performance of an Implantable CGM System through 180 Days in a Primarily Adolescent Population with Type 1 Diabetes,” in the official Press Program for ADA. This study will be summarized for reporters at the American Diabetes Association News Briefing highlighting the latest research on Advances in Technology, presented to more than 200 journalists around the world!

 

 Dr. Aronson’s study was selected based on its overall excellence in furthering research and treatment for people with diabetes, as well as its potential appeal to the medical/scientific and general news media. Dr. Aronson & LMC’s  participation in the Scientific Session’s Press Program will help further the ADA’s goal of keeping the medical and patient communities informed about the latest advances in the clinical and translational advances in diabetes.

 

We hope we see you at ADA in Orlando this year! To schedule a time to meet, and discuss the evolution, growth, and possibilities of LMC Healthcare & LMC Manna Research, contact us at the information listed below!

 

Ronnie Aronson
CMO
ronnie.aronson@LMC.ca

Mark Angelo
CEO
mark.angelo@LMC.ca

Karri Venn
President, Research
647-274-4133
karri.venn@LMC.ca